Table 1. General characteristics of the sample.
| Bilevel Group (n=25) | 95%CI Bilevel Group | HFNC Group (n=25) | 95%CI HFNC Group | Adjusted mean difference of the 95% CI | |
|---|---|---|---|---|---|
| Age (years) | 7.2±1.9 | (7.21–7.31) | 7.62±1.8 | (7.60–7.64) | (-1.09; 1.16) |
| Sex (M/F) | 15/10 | - | 13/12 | - | - |
| Height (cm) | 129.7±10.1 | (129.46–130.28) | 126.7±10.7 | (126.35–127.14) | (-9.05; 2.59) |
| Weight (kg) | 29.4±7.2 | (29.18–29.37) | 28.4±8.2 | (28.31–28.48) | (-5.72; 2.82) |
| Asthma attacks (within 12 months) | 2.75±1.9 | (2.74–2.75) | 2.0±1.5 | (2.04–2.05) | (-1.65; 0.19) |
| Hospitalizations (within 12 months) | 1.25±1.05 | (1.24–1.25) | 1.4±1 | (1.39–1.4) | (-0.61; 0.49) |
| Systemic corticosteroids (mg/6h) | 24.85±6.75 | (24.77–24.93) | 25.84±7.26 | (25.76–25.72) | (-3.64; 3.25) |
| FVC (%) | 40±19.7 | (39.87–40.12) | 38.6±17.1 | (38.49–38.73) | (-9.83; 12.57) |
| FEV1 (%) | 32.11±12.1 | (32.01–32.21) | 31±١١.٣ | (30.9–31.09) | (-6.83; 7.26) |
| FEF25%-75% | 24.58±15.0 | (24.51–24.66) | 24.3±15.6 | (24.25–24.40) | (-13.06; 5.38) |
| PEF (%) | 34.41±19.3 | (34.30–34.51) | 31.9±17.6 | (3.84–31.93) | (-12.35; 10.04) |
| PASS | 3.19±0.67 | (3.18–3.20) | 3.68±1.05 | (3.67-3.69) | (-0.11; 0.84) |
| PAS | 10.47±1.4 | (10.44–10.5) | 10.78±1.65 | (10.75-10.82) | (-0.65; 0.93) |
| PIS | 5.42±1.07 | (5.41–5.44) | 5.94±1.74 | (5.92-5.96) | (-0.48; 0.93) |
| Days of hospitalization | 6.87±4.6 | (6.85–6.89) | 4.25±1.37* | (4.23–4.26) | (-5.00; -0.69) |
| Days of oxygen use | 5.16±3.4 | (5.15–5.18) | 2.95±1.27* | (2.94–2.95) | (-3.52; -0.54) |
*p<0.05.
95%CI: 95% confidence interval; F: female; FEF: forced expiratory flow; FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; HFNC: high-flow nasal cannula; M: male; PAS: pediatric asthma score; PASS: pediatric asthma severity score; PEF: peak expiratory flow; PIS: pulmonary index score.